期刊文献+

表达HBsAg特异性siRNA的重组腺相关病毒载体的构建 被引量:5

Inhibition of HbsAg and HbeAg expression of recombinant adeno-associated virus encoding HBsAg-shRNA in HepG2.215 cells in vitro
下载PDF
导出
摘要 目的构建表达针对HBsAg小发卡RNA(shRNA)的重组腺相关病毒载体,以观察该病毒在体外对HBsAg和HBeAg的抑制作用。方法将表达针对HBsAg的shRNA定向克隆到pAAV/U6-hrGFP质粒中,获得重组表达质粒(pAAV-shHBs-hrGFP);采用磷酸钙转染法将该质粒与包装质粒pAAV-RC和辅助质粒pHelper共同转染AAV293细胞,进行rAAV-shHBs-hrGFP重组病毒包装。收获病毒感染HepG2.215细胞;采用ELISA法检测HBsAg和HBeAg水平。结果酶切鉴定、测序结果表明,pAAV-shHBs-hrGFP载体成功构建。包装收获的rAAV-shHBs-hrGFP病毒液可以感染HepG2.215细胞,并且可以抑制HBsAg和HBeAg的表达。结论制备的rAAV-shHBs-hrGFP病毒载体能够抑制HBV在体外的抗原表达。 Objective To construct the recombinant adeno-associated virus(rAAV)encoding HBsAg-shRNA and to observe its effect on HBsAg and HBeAg expression in HepG2215 cells in vitro. Methods pAAV-shHBs-hrGFP expressing plasmid was constructed by molecular biological techniques. The recombinants were cotransfected with p-RC and p-Helper into AAV-293 cells mediated by calcium acid phosphate. The rAAVs encoding HBsAg-shRNA (rAAV-shHBs-hrGFP)were harvested and infected HepG2215 cells. The silencing effect of this virus on HbsAg and HBeAg gene expression was assessed by ELISA. Results The plasmid of pAAV-shHBs-hrGFP was successfully constructed by identification of restrict enzyme and DNA sequencing. GFP expression was observed about 80% in AAV-293 cells. After cotransfection,the recombinant AAV-shHBs-hrGFP was harvested and the virus titer was tested. The HBsAg and HBeAg expression in HepG2.215 cells was down-regulated markedly after infection of rAAV -shHBs -hrGFP. Conclusion The recombinant AAV -shHBs -hrGFP vector is successfully constructed and can be used as a potential antivirus agent to inhibit HBV replication.
出处 《实用肝脏病杂志》 CAS 2010年第3期161-165,共5页 Journal of Practical Hepatology
基金 国家传染病防治科技重大专项(2008ZX10002-011) 国家高技术研究发展计划(863)项目(2006AA02Z128) 国家自然科学基金(30700701)
关键词 HepG2.215细胞 腺相关病毒2 RNA干扰 HBSAG HepG2215 cells AAV2 RNAi HBsAg
  • 相关文献

参考文献16

  • 1OCAMA P,OPIO CK,LEE WM.Hepatitis B virus infection:current status[J].Am J Med,2005,118(12):1413.
  • 2WRIGHT TL.Introduction to chronic hepatitis B infection[J].Am J Gastroenterol,2006,101:1-6.
  • 3LEE S,KIM S.Gene regulations in HBV-related liver cirrhosis closely correlated with disease severity[J].J Biochem Mol Biol,2007,40(5):814-824.
  • 4BUTI M,RODRIGUEZ FF,JARDI R,et al.Hepatitis B virus genome variability and disease progression:the impact of pre-core mutants and HBV genotypes[J].J Clin Virol,2003,34(Suppl 1)S79-S82.
  • 5MARCELLIN 2003 P.Advances in therapy for chronic hepatitisB[J].Semin Liver Dis,2002,22(Suppl 1):33-36.
  • 6WU H L,HUANG LR,HUANG CC,et al.RNA interference-mediated control of hepatitis B virus and emergence of resistant mutant[J].Gastroenterology,2005,128(3):708-716.
  • 7SUN Y,LI Z,LI L,et al.Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors[J].Int J Mol Med,2007,19(4):705-711.
  • 8FLOTTE TR.Gene therapy progress and prospects:recombinant adeno-asseciated virus(rAAV)vectors[J].Gene Ther,2004,11(10):805-810.
  • 9张正茂,田拥军,孟忠吉,雷延昌,李新宇,王宝菊,杨东亮.RNA干扰抑制人乙型肝炎病毒复制的研究[J].中国病毒学,2006,21(4):348-352. 被引量:6
  • 10MCCARTY DM,YOUNG SM,SAMULSKI RJ.Integration of adeno-associated virus(AAV)and recombinant AAV vectors[J].Annu Rev Genet,2004,38(1):819-845.

二级参考文献4

共引文献5

同被引文献81

  • 1张正茂,田拥军,孟忠吉,雷延昌,李新宇,王宝菊,杨东亮.RNA干扰抑制人乙型肝炎病毒复制的研究[J].中国病毒学,2006,21(4):348-352. 被引量:6
  • 2王玥,牛俊奇,丁艳华,王峰.应用RNA干扰抑制乙型肝炎病毒复制和表达[J].中华肝脏病杂志,2006,14(10):790-792. 被引量:6
  • 3SHOHEI K,KEN JI,CEVAYIR C,et al. Innate immune response to viral infection[J]. Cytokine,2008,43:336-341.
  • 4DIANA LR,LARS E,MICHAEL BD,et al. Human hepatocytes express an array of proinflammatory cytokines after agonist stimulation or bacterial invasion[J]. Am J Physiol Gastrointest Liver Physiol, 1997,273:322-332.
  • 5ILMARS S,ELITA S,STEFAN R,et al. HepG2 human hepatoma ceils express multiple cytokine genes[J]. Cytokine, 1999, 11(2):151-156.
  • 6PREISS S,THOMPSON A,CI-IEN X,et al. Characterization of the innate immune signalling pathways in hepatocyte cell lines[J]. J Viral Hepat,2008,15:888-900.
  • 7XIA C,LU MJ. TLRs antiviral effect on hepatitis B virus in HepG2 cells[J]. J Appl Microbiol,2008,105(5): 1720-1727.
  • 8ISOGAWA M,ROBEK MD,FURUICHI Y,et al. Toll-like receptor signaling inhibits hepatitis B virus replication in vivo[J]. J Viral,2005,79:7269-7272.
  • 9WU J,LU MJ,MENG ZJ,et al. Toll-like receptor-mediated control of HBV replication by nonparenchymal liver ceils in mice[J]. Hepatology, 2007,46(6):1769-1778.
  • 10WU J,MENG ZJ,JIANG M,et al. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells[J]. Hepatology, 2009,49(4):1132-1140.

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部